HJ Kolb

5.2k total citations · 1 hit paper
50 papers, 3.7k citations indexed

About

HJ Kolb is a scholar working on Hematology, Immunology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, HJ Kolb has authored 50 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Hematology, 14 papers in Immunology and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in HJ Kolb's work include Hematopoietic Stem Cell Transplantation (30 papers), Immunotherapy and Immune Responses (10 papers) and Chronic Myeloid Leukemia Treatments (9 papers). HJ Kolb is often cited by papers focused on Hematopoietic Stem Cell Transplantation (30 papers), Immunotherapy and Immune Responses (10 papers) and Chronic Myeloid Leukemia Treatments (9 papers). HJ Kolb collaborates with scholars based in Germany, France and United Kingdom. HJ Kolb's co-authors include William Arcese, JM Goldman, Dietger Niederwieser, Per Ljungman, N Jacobsen, Augustin Ferrant, Leo F. Verdonck, A Schattenberg, Bernd Hertenstein and Ernst Holler and has published in prestigious journals such as The Lancet, Blood and British Journal of Haematology.

In The Last Decade

HJ Kolb

49 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia [see comments]

1995 1.5k citations HJ Kolb, JM Goldman et al. Blood profile →

Peers

Countries citing papers authored by HJ Kolb

Since Specialization

Citations

This map shows the geographic impact of HJ Kolb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by HJ Kolb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites HJ Kolb more than expected).

Fields of papers citing papers by HJ Kolb

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by HJ Kolb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by HJ Kolb. The network helps show where HJ Kolb may publish in the future.

Co-authorship network of co-authors of HJ Kolb

This figure shows the co-authorship network connecting the top 25 collaborators of HJ Kolb. A scholar is included among the top collaborators of HJ Kolb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with HJ Kolb. HJ Kolb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mechanisms of graft-versus-leukemia effects after allogeneic stem cell transplantation: effects on the leukemia stem cell? 2014 ·PubMed ·HJ Kolb, (unknown), (unknown), (unknown), Raymund Buhmann, Andreas Moosmann, Christine S. Falk, (unknown), Friedhelm R. Schuster, Arndt Borkhardt	3
2	Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia 2011 ·Leukemia ·Charles Craddock, Myriam Labopin, Srinivas Pillai, Jürgen Finke, Donald Bunjes, Hildegard Greinix, Gerhard Ehninger, (unknown), A R Zander, Rainer Schwerdtfeger, Stefanie Buchholz, HJ Kolb, Liisa Volin, A. A. Fauser, Emmanuelle Polge, Christoph Schmid, Mohamad Mohty, Vanderson Rocha	94
3	Prospective evaluation of neurological complications after allogeneic bone marrow transplantation (vol 60, pg 842, 2006) 2006 ·UCL Discovery (University College London) ·P. Sostak, (unknown), (unknown), Georg Ledderose, HJ Kolb, Andreas Straube	4
4	Adoption of long-term cultures to evaluate the cryoprotective potential of trehalose for freezing hematopoietic stem cells 2004 ·Bone Marrow Transplantation ·(unknown), (unknown), HJ Kolb, Michael Schleuning	36
5	Dose-dependent effects of in vivo antithymocyte globulin during conditioning for allogeneic bone marrow transplantation from unrelated donors in patients with chronic phase CML 2003 ·Bone Marrow Transplantation ·Michael Schleuning, W. Günther, Johanna Tischer, (unknown), HJ Kolb	32
6	ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML) 2003 ·Bone Marrow Transplantation ·A R Zander, Nicolaus Kröger, Michael Schleuning, Jürgen Finke, Tatjana Zabelina, Dietrich W. Beelen, Rainer Schwerdtfeger, (unknown), Martin Bornhäuser, G. Ehninger, A. A. Fauser, Michael Kiehl, Rudolf Trenschel, Hellmut Ottinger, H Bertz, J. Berger, HJ Kolb, (unknown)	42
7	New concepts about graft-versus-host and graft-versus-leukaemia-reactions. A summary of the 5th International Symposium held in Munich, 21 and 22 March 2002 2002 ·Bone Marrow Transplantation ·Reinhold Munker, W. Günther, HJ Kolb	3
8	The impact of antithymocyte globulin on short-term toxicity after allogeneic stem cell transplantation 2002 ·Bone Marrow Transplantation ·Rudolf Pihusch, Ernst Holler, Dieter Mühlbayer, (unknown), Oliver Stötzer, Markus Pihusch, Erhard Hiller, HJ Kolb	48
9	The detection of apoptosis in a human in vitro skin explant assay for graft versus host reactions 2002 ·Journal of Clinical Pathology ·M. Jarvis, Ulrike Schulz, Anne M. Dickinson, Lisbet Sviland, G Jackson, Abdo Konur, (unknown), Ilona Hromadníková, HJ Kolb, Günther Eißner, Ernst Holler	21
10	Nutritional status and growth after bone marrow transplantation (BMT) during childhood: EBMT Late-Effects Working Party retrospective data 1999 ·Bone Marrow Transplantation ·A Cohen, Thomas Duell, Gèrard Socié, (unknown), (unknown), André Tichelli, Attilio Rovelli, JF Apperley, Per Ljungman, HJ Kolb, (unknown)	20
11	The Relevance of Plasminogen Activator Inhibitor 1 (PAI-1) as a Marker for the Diagnosis of Hepatic Veno-Occlusive Disease in Patients after Bone Marrow Transplantation 1999 ·Leukemia & lymphoma ·Christoph Salat, Ernst Holler, HJ Kolb, Rudolf Pihusch, (unknown), (unknown), Georg Ledderose, Eliza C. Miller	21
12	Donor Leukocyte Transfusions for Treatment of Leukemic Relapse after Bone Marrow Transplantation 1998 ·Vox Sanguinis ·HJ Kolb, (unknown)	58
13	Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation 1998 ·The Lancet ·Aloïs Gratwohl, J. Hermans, JM Goldman, William Arcese, Enric Carreras, A Devergié, Francesco Frassoni, (unknown), HJ Kolb, D Niederwieser, Tapani Ruutu, Vernant Jp, T. de Witte, J. Apperley	451
14	Donor search or autografting in patients with acute leukaemia who lack an HLA-identical sibling? A matched-pair analysis 1997 ·Bone Marrow Transplantation ·Olle Ringdén, Myriam Labopin, Éliane Gluckman, JM Hows, B Bradley, HJ Kolb, L Fouillard, N Jacobsen, Vernant Jp, Francis Witz, Harousseau Jl, Gorin Nc	36
15	Chronic myeloid leukemia associated hypereosinophilic syndrome with a clonal t(4;7)(q11;q32) 1997 ·Cancer Genetics and Cytogenetics ·Thomas Duell, J. Mittermüller, Helga Schmetzer, HJ Kolb, W. Wilmanns	13
16	MALIGNANT DISEASES AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION: THE CASE FOR ASSESSMENT OF RISK FACTORS 1992 ·British Journal of Haematology ·Gèrard Socié, HJ Kolb, Per Ljungman	14
17	Low Incidence of Transplant-Related Complications in Patients with Chronic Release of Tumor Necrosis Factor-Alpha before Admission to Bone Marrow Transplantation: A Clinical Correlate of Cytokine Desensitization? 1991 ·Pathobiology ·Ernst Holler, R. Hintermeíer-Knabe, HJ Kolb, J. Kempeni, (unknown), S.M. Liesenfeld, (unknown), W. Wilmanns	7
18	Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation 1989 ·Blood ·Ernst Holler, HJ Kolb, Erhard Hiller, W. Mraz, Walter Lehmacher, (unknown), (unknown), U. Jehn, H Gerhartz, G. Brehm	155
19	Allogeneic bone marrow transplantation for leukaemia in Europe 1988 ·The Lancet ·Aloïs Gratwohl, J. Hermans, A. John Barrett, P Ernst, Francesco Frassoni, Gösta Gahrton, A Grañena, HJ Kolb, A Marmont, H. G. Prentice, B Speck, Vernant Jp, (unknown)	65
20	Rh antibodies against the pretransplant red cells following Rh‐incompatible bone marrow transplantation 1988 ·Transfusion ·M. U. Heim, Michael Schleuning, R. Eckstein, D. Huhn, W. Siegert, Ch. Clemm, Georg Ledderose, HJ Kolb, W. Wilmanns, W Mempel	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact